Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-12-019199
Filing Date
2012-04-02
Accepted
2012-04-02 07:12:16
Documents
11
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K v307389_10k.htm 10-K 754927
2 EXHIBIT 23 v307389_ex23.htm EX-23 4850
3 EXHIBIT 31.1 v307389_ex31-1.htm EX-31.1 10682
4 EXHIBIT 31.2 v307389_ex31-2.htm EX-31.2 10371
5 EXHIBIT 32 v307389_ex32.htm EX-32 6740
  Complete submission text file 0001144204-12-019199.txt   2873556

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rgdx-20111231.xml EX-101.INS 355754
7 XBRL TAXONOMY EXTENSION SCHEMA rgdx-20111231.xsd EX-101.SCH 15967
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rgdx-20111231_cal.xml EX-101.CAL 38056
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rgdx-20111231_def.xml EX-101.DEF 99050
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgdx-20111231_lab.xml EX-101.LAB 119240
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgdx-20111231_pre.xml EX-101.PRE 119411
Mailing Address 1640 MARENGO ST., 6TH FLOOR LOS ANGELES, CA 90033
Business Address 1640 MARENGO ST., 6TH FLOOR LOS ANGELES, CA 90033 (323) 224-3900
RESPONSE GENETICS INC (Filer) CIK: 0001124608 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33509 | Film No.: 12731155
SIC: 2835 In Vitro & In Vivo Diagnostic Substances